Facilitators and barriers to traditional medicine use among cancer patients in Malawi
Autoři:
Jacob Hill aff001; Ryan Seguin aff002; Twambilile Phanga aff002; Agness Manda aff002; Maria Chikasema aff002; Satish Gopal aff001; Jennifer S. Smith aff001
Působiště autorů:
University of North Carolina, Chapel Hill, North Carolina, United States of America
aff001; Malawi Cancer Consortium and Regional Center of Research Excellence for non-Communicable Diseases, Lilongwe, Malawi
aff002; University of Malawi College of Medicine, Blantyre, Malawi
aff003
Vyšlo v časopise:
PLoS ONE 14(10)
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pone.0223853
Souhrn
Background
Increasing access to conventional cancer treatment (CT) in low-income countries (LICs) is an important public health initiative to address the global burden of cancer. However, LICs have a high prevalence of use of traditional and complementary medicine (T&CM). It is important to consider the factors that influence a patient’s choice to use T&CM, CT, or both for their cancer treatment.
Methods
We conducted focus groups among adult cancer patients in Lilongwe, Malawi to identify facilitators and barriers of T&CM use. Focus groups were recorded, transcribed, translated, and underwent thematic content analysis.
Results
Cultural norms, T&CM access, T&CM success, and CT failure were all identified as facilitators to T&CM use. CT success and T&CM failure were identified as barriers. Access and norms appear to determine initial treatment selection, while treatment outcomes dictate continued use of T&CM or CT.
Conclusion
This study identified a pragmatic and experience-based treatment selection process that aligns with the social cognitive theory of behavior and assists in comprehending the factors that influence T&CM use among cancer patients in a low resource setting.
Klíčová slova:
Health care facilities – Cancer treatment – Behavior – Cancer detection and diagnosis – Health care policy – Culture – Traditional medicine – Malawi
Zdroje
1. Bodeker G, Kronenberg F. A public health agenda for traditional, complementary, and alternative medicine. Am J Public Health [Internet]. 2002 Oct [cited 2019 Apr 2];92(10):1582–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12356597%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3221447 doi: 10.2105/ajph.92.10.1582 12356597
2. Bannerman R, Burton J, Chien W. Traditional Medicine and Healthcare Coverage. Geneva, Switzerland; 1993.
3. World Health Organization. WHO Traditional Medicine Strategy 2002–2005. WHO Tradit Med Strateg World Heal Organ Geneva [Internet]. 2002 [cited 2019 Apr 2]; Available from: http://www.wpro.who.int/health_technology/book_who_traditional_medicine_strategy_2002_2005.pdf
4. World Health Organization. WHO Traditional Medicine Strategy 2014–2023. 2013; Available from: http://apps.who.int/iris/bitstream/10665/92455/1/9789241506090_eng.pdf
5. James PB, Wardle J, Steel A, Adams J. Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review. BMJ Glob Heal [Internet]. 2018 [cited 2019 Jul 12];3:895. Available from: http://gh.bmj.com/
6. Hill J, Mills C, Li Q, Smith JS. Prevalence of traditional, complementary, and alternative medicine use by cancer patients in low income and lower-middle income countries. Glob Public Health [Internet]. 2018 Oct 16 [cited 2019 Apr 2];1–13. Available from: https://www.tandfonline.com/doi/full/10.1080/17441692.2018.1534254
7. Block KI, Gyllenhaal C. Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes. Integr Cancer Ther [Internet]. 2002;1(1):83–9. Available from: http://ict.sagepub.com/content/1/1/83.full.pdf doi: 10.1177/153473540200100118 14664751
8. Davis EL, Oh B, Butow PN, Mullan BA, Clarke S. Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: A Systematic Review. Oncologist [Internet]. 2012 Nov [cited 2019 Apr 2];17(11):1475–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22933591 doi: 10.1634/theoncologist.2012-0223 22933591
9. Obrist M, Osei-Bonsu E, Awuah B, Watanabe-Galloway S, Merajver SD, Schmid K, et al. Factors related to incomplete treatment of breast cancer in Kumasi, Ghana. The Breast. 2014;23(6):821–8. doi: 10.1016/j.breast.2014.08.014 25282667
10. Dunyo SK, Ahorlu CK, Simonsen PE. Scarification as a risk factor for rapid progression of filarial elephantiasis. Trans R Soc Trop Med Hyg [Internet]. [cited 2019 Apr 2];91(4):446. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9373650
11. Letsyo E, Jerz G, Winterhalter P, Beuerle T. Toxic pyrrolizidine alkaloids in herbal medicines commonly used in Ghana. J Ethnopharmacol [Internet]. 2017 Apr 18 [cited 2019 Apr 2];202:154–61. Available from: https://www.sciencedirect.com/science/article/pii/S037887411730154X?via%3Dihub doi: 10.1016/j.jep.2017.03.008 28284793
12. De Boer C, Niyonzima N, Orem J, Bartlett J, Zafar SY. Prognosis and delay of diagnosis among Kaposi’s sarcoma patients in Uganda: a cross-sectional study. Infect Agent Cancer [Internet]. 2014 [cited 2019 Apr 2];9:17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24904686 doi: 10.1186/1750-9378-9-17 24904686
13. Malawi Ministry of Health. Health Sector Strategic Plan II (2017–2022). Gov Repub Malawi. 2017;
14. Ministry of Health Malawi. Health Sector Strategic Plan I 2011–2016. 2012;170.
15. Hillenbrand E. Improving Traditional-Conventional Medicine Collaboration: Perspectives from Cameroonian Traditional Practitioners. Nord J African Stud. 2006;15(1):1–15.
16. Bandura A. Social Cognitive Theory [Internet]. Vol. 6, Annals of child development. JAI Press; 1989 [cited 2019 Apr 2]. Available from: https://www.uky.edu/~eushe2/Bandura/Bandura1989ACD.pdf
17. Glanz K, Rimer BK, Viswanath K (Kasisomayajula). Health behavior: theory, research, and practice [Internet]. [cited 2019 Apr 2]. 485 p. Available from: https://www.wiley.com/en-us/Health+Behavior%3A+Theory%2C+Research%2C+and+Practice%2C+5th+Edition-p-9781118628980
18. Wang Q, Fu AZ, Brenner S, Kalmus O, Banda HT, De Allegri M. Out-of-Pocket Expenditure on Chronic Non-Communicable Diseases in Sub-Saharan Africa: The Case of Rural Malawi. Catapano A, editor. PLoS One [Internet]. 2015 Jan 13 [cited 2019 Apr 2];10(1):e0116897. Available from: doi: 10.1371/journal.pone.0116897 25584960
19. Fisher E, Lazarus R, Asgary R. Attitudes and Perceptions Towards Access and Use of the Formal Healthcare Sector in Northern Malawi. J Health Care Poor Underserved [Internet]. 2017 [cited 2019 Apr 2];28(3):1104–15. Available from: https://muse.jhu.edu/article/666601 doi: 10.1353/hpu.2017.0100 28804081
20. Chibwana AI, Mathanga DP, Chinkhumba J, Campbell CH. Socio-cultural predictors of health-seeking behaviour for febrile under-five children in Mwanza-Neno district, Malawi. Malar J [Internet]. 2009 Dec 24 [cited 2019 Mar 5];8(1):219. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-8-219
21. Moshabela M, Bukenya D, Wamoyi J, Hosegood V, Bonnington O, Ondeng’e K, et al. Traditional healers, faith healers and medical practitioners: the contribution of medical pluralism to bottlenecks along the cascade of care for HIV/AIDS in Eastern and Southern Africa. Sex Transm Infect. 2017;93(Suppl 3):e052974. doi: 10.1136/sextrans-2016-052974 28736393
22. WHO global report on traditional and complementary medicine 2019 [Internet]. World Health Organization; 2019 [cited 2019 Jul 13]. Available from: http://apps.who.int/bookorders.
Článok vyšiel v časopise
PLOS One
2019 Číslo 10
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Těžké menstruační krvácení může značit poruchu krevní srážlivosti. Jaký management vyšetření a léčby je v takovém případě vhodný?
- Fixní kombinace paracetamol/kodein nabízí synergické analgetické účinky
Najčítanejšie v tomto čísle
- Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
- Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity
- Experimentally validated simulation of coronary stents considering different dogboning ratios and asymmetric stent positioning
- Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis